Chinese Academy of Sciences;Shanghai Institutes for Biological Sciences
发明人:
Shi, Yufang,Wang, Ying,Du, Liming,Lin, Liangyu
申请号：
AU2017370226
公开号：
AU2017370226A1
申请日:
2017.11.28
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
Provided is the use of an insulin-like growth factor-2 for preparing a pharmaceutical composition, wherein the pharmaceutical composition is used for (i) promoting the expression of the macrophage PD-L1, and/or (ii) inhibiting the expression of the macrophage IL-1β. Also provided is a pharmaceutical composition containing the insulin-like growth factor-2 as an active ingredient.
